CXCL8 and neoplasm: If a similar response was invoked in tumour tissue during therapeutic inhibition of glutamine metabolism, the secretion of autocrine/paracrine-acting IL-8 might have significant effects on tumour pathophysiology and the tumour–host interface, which could lead to changes in therapeutic responsiveness.